These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 17449212
1. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection. Rouse MS, Steckelberg JM, Patel R. Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212 [Abstract] [Full Text] [Related]
2. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M, Grupo VIRA. Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [Abstract] [Full Text] [Related]
3. Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers. Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López F, VIRA Study Group. Diagn Microbiol Infect Dis; 2009 Aug; 64(4):448-51. PubMed ID: 19631100 [Abstract] [Full Text] [Related]
4. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients. Kratzer C, Rabitsch W, Hirschl AM, Graninger W, Presterl E. Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506 [Abstract] [Full Text] [Related]
11. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Isnard C, Dhalluin A, Malandain D, Bruey Q, Auzou M, Michon J, Giard JC, Guérin F, Cattoir V. J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316 [Abstract] [Full Text] [Related]
12. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124 [Abstract] [Full Text] [Related]
13. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008). Mendes RE, Sader HS, Jones RN. Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860 [Abstract] [Full Text] [Related]
17. In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC. Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS. Diagn Microbiol Infect Dis; 2012 Jul; 73(3):264-6. PubMed ID: 22621914 [Abstract] [Full Text] [Related]
19. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS, Jones RN, Rossi KL, Rybak MJ. J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [Abstract] [Full Text] [Related]